Concentrated samples of saliva, urine, and seminal fluid from 23 men with chronic liver disease who were positive for hepatitis B e antigen were examined for the presence of hepatitis B virus deoxyribonucleic acid (HBV-DNA) by molecular hybridisation. HBV-DNA was detected in saliva from 15 of 17 men (88%), urine from 12 of 22 men (55%), and seminal fluid from 13 of 21 men (62%). The presence of hepatitis B virus in such secretions has important epidemiological implications for heterosexual and homosexual contact.
Introduction
The parenteral mode of transmission of hepatitis B virus is well established, but non-parenteral (or inapparent parenteral) routes of exposure may also play a part in infectivity; this may explain the high incidence of transmission of hepatitis B virus among homosexual men and family contacts of carriers of hepatitis B virus.'-7 Several groups have therefore examined bodily fluids and secretions for the presence of hepatitis B surface antigen (HBsAg), which has been found in saliva, [8] [9] [10] urine,'-"2 semen,8 breast milk,13 14 vaginal secretions and menstrual blood,15 16 and pancreatic and biliary secretions."7 There are conflicting reports of its presence in faeces. 10 18-20 The detection of HBsAg alone, however, does not by itself denote potential infectivity as HBsAg may be found in the absence of infectious virions. The potential for transmission of hepatitis B virus by inapparent parenteral means has therefore not been fully evaluated.
The presence of hepatitis B virus particles can be detected by molecular hybridisation techniques, which detect hepatitis virus deoxyribonucleic acid (HBV-DNA).2"-25 The presence of HBV-DNA indicates potential infectivity. In this study we examined concentrated saliva, urine, and seminal fluid for the presence of HBV-DNA by molecular hybridisation. The results were correlated with serum concentrations of HBV-DNA and with the possible contamination of saliva and urine with blood.
Patients and methods
Twenty three patients with chronic hepatitis B virus infection (positive for HBsAg, hepatitis B e antigen (HBeAg), and HBV-DNA) who attended this hospital for antiviral treatment participated in the study. Two carriers positive for HBsAg and anti-HBe and a healthy subject negative for HBsAg served as controls. Eighteen of the participants provided samples of all the secretions that were requested (group 1). The remaining eight patients (group 2) either failed to provide some of the samples or provided insufficient samples.
Patients were issued with receptacles for the specimens and were asked to collect about 3 ml saliva when they woke up in the morning and before brushing their teeth; 50 ml urine voided in the morning; and a sample of semen obtained preferably after abstention from sexual activity for three days. A specimen of serum was obtained on the same day by venepuncture.
All specimens were processed within two to three hours after collection. Specimens of saliva and urine were tested for the presence of blood by Hemastix (Ames Division, Miles Laboratories, Slough) before concentration. Samples of semen were allowed to liquefy at room temperature, and the sperm were then separated from the seminal fluid by centrifugation.
The saliva, urine, and seminal fluid were next placed in dialysis tubing and concentrated against macrogol 6000 (polyethylene glycol 6000) (BDH Chemicals, Poole). Saliva and seminal fluid were concentrated to 250 IL irrespective of starting volume. Urine was concentrated from a 25 ml starting volume to 250 pl (100-fold concentration). All samples were then stored at -20°C.
The methods of HBV-DNA extraction, preparation of radiolabelled probes by nick translation, and molecular hybridisation have been described previously.2' 2628 Viral DNA from saliva, urine, and seminal fluid was extracted as for serum. Autoradiographs were obtained by exposure of hybridised DNA on nitrocellulose filters for 24-48 hours. Samples from four patients were also analysed by agarose gel electrophoresis and Southern blotting followed by hybridisation with HBV-DNA labelled with phosphorus-32. 26 
Results
The table shows the incidence of HBV-DNA in saliva, urine, and seminal fluid. HBV-DNA was detected in 55-88% of the samples from the HBeAg positive patients and none from the controls. Moreover, in group 1 at least one sample from every patient was positive for HBV-DNA and all 15 patients were therefore potentially infectious. Nine of these patients provided samples on a second occasion and similar positivity rates were obtained.
To confirm that the results obtained were due to HBV-DNA, samples were examined by Southern blotting to investigate the molecular species of the hybridisable DNA. Hybridisation signals in the form of smears covering the size range 2-0-2-8 kb were seen. These corresponded to the heterogeneous population of HBV-DNA associated with virions. The intensity of the autoradiography spots (figure) from all secretions was generally weak and required at least 48 hours of film exposure before becoming visible. This was particularly true for the samples of seminal fluid. Several specimens of saliva and urine, however, produced strong spots within 24 hours. Serum concentrations of HBV-DNA ranged from 8-94xlO-11 to 2 77 x 10-1 mmol/l (186 to 5760 pg/ml).
Samples of urine and saliva were examined for blood. None of the samples of urine contained detectable amounts of blood. In the saliva, however, blood was detected in varying amounts (two trace, four small, two moderate, and three large) in 11 of the 17 Of the concentrated saliva specimens, 87% were positive for HBV-DNA, and in some large amounts were present. The detection of HBV-DNA in some of these may have been due to the presence of oral or gingival lesions as blood was detected in 64% of the samples and this was gross in 31%. In some cases, however, HBV-DNA was detected in saliva with no detectable contamination with blood. Of the concentrated urine specimens, 60% were positive for HBV-DNA and none were contaminated with blood. This prevalence was higher than previous reports of HBsAg in urine,9 10 possibly because of the greater degree of concentration achieved here and the more sensitive technique of molecular hybridisation. Seminal fluid was also found to be positive for HBV-DNA. The degree of concentration varied from twofold to 10-fold depending on the volume of the ejaculate.
The presence of HBV-DNA in the above secretions was independent of the amount of HBV-DNA in serum. Although no quantitative measurements were undertaken owing to the difficulty in standardising concentration factors, the amounts detected in the various secretions were small compared with those found in serum. Probably there is transudation or exudation of fluid containing virus from the general circulation into various body fluids rather than active virus replication at the site of secretion.
The presence of HBV-DNA in the various secretions was further confirmed by Southern blotting. Positive autoradiographs were obtained from smears of HBV-DNA sequences in the 2-0-2-8 kb region of the gels, where HBV-DNA associated with virions is normally found.26
Most of the men investigated were homosexual, and all of them had at least one sample that was positive for HBV-DNA. It has been postulated that the high rate of transmission of hepatitis B virus in homosexual populations is due to contamination of partners with blood from lacerations in the rectum of the passive partner or cuts on the penis of the active partner.20 Our results prove that this may not be the only mechanism. Contaminated semen or saliva deposited in the rectum during orogenital and oroanal contact might be alternative modes of transmission among homosexual men. Similarly, consorts of heterosexual men are at risk of infection from their partner's secretions. Indeed the potential of saliva and semen to transmit hepatitis B virus infection has been shown experimentally in primates.29 30 
Introduction
Chronic ulceration of the leg appears to have perplexed physicians since medical records began. Although there are many reports on its management, little information is available on the overall size and extent of the problem or its clinical course.
Two European surveys into venous disease have been made, providing data on the prevalence of leg ulceration. The first was a study, based on a questionnaire, of the adult population of Klatov in Bohemia in 1961 by Bobek et al.' Those people who indicated that they had evidence of venous disease were subsequently examined. This survey showed that the prevalence of leg ulceration, either open or healed, was 1'. The second and more recent study, of factory workers in Basle, Switzerland, showed a similar proportion.2
Information concerning the United Kingdom is almost nonexistent. In 1929 Dickson-Wright suggested a prevalence of 0-5% but admitted that this figure was an estimate.3 In 1951 Boyd et al arrived at a similar figure based on the returns of patients registered as off work due to leg ulceration,4 but this figure was probably an underestimate. In a study supplementary to that reported here and based on patients in a group practice in Edinburgh we recently estimated that 1% of adults suffer from chronic leg ulcers. 5 Much of the information in reports on leg ulcers is based on small, selected populations, usually patients attending outpatient departments. An understandable conclusion that might be drawn from such reports is that all leg ulcers are managed by dermatologists, surgeons, or physiotherapists. A preliminary survey by our own group, however, showed that most patients were cared for in the community by district nurses and represented a formidable problem for the primary care services not only in terms of numbers but also in various aspects of management.
We concluded that the first step towards improving care was to obtain better information on the scale of the problem, the clinical course of the condition, and how care was being provided.
The Lothian and Forth Valley leg ulcer study was therefore set up in 1981. This paper reports the first phase, the main aims of which were to establish a point prevalence of leg ulcers and to find out who was providing the care.
Methods
The survey was carried out in 1981-2 in the neighbouring health board areas of Lothian and Forth Valley, which have a mixed urban and rural population of about one million. The objective was to identify all patients receiving treatment for chronic leg ulceration from any branch of the National Health Service at the time of the survey.
To identify all patients receiving treatment in the community recording forms were sent to all general practitioners, district and occupational nurses, and wardens of old people's homes. To identify patients receiving either outpatient or inpatient care at a hospital forms were sent to outpatient departments, physiotherapy departments, and inpatient wards of general hospitals and all acute and long stay hospitals. In each case the correspondent was asked to identify all the patients currently undergoing treatment for active chronic leg ulceration or who had received treatment within three months. Efforts were made to obtain replies from non-responders by means of follow up letters and telephone calls.
The resulting returns were cross checked to ensure that patients reported from more than one source were included only once in the final total.
Results
Of the 572 general practitioners approached, only 37 refused to cooperate with the study. Complete returns were obtained from all other correspondent groups. Notifications of 2128 patients were received, of which 651 were reported from more than one source, giving a total of 1477 patients (1765 (83%) were reported by general practitioners, district nurses, occupational health services, and old people's homes; and 104 (5%) by physiotherapy departments, 148 (7%) by
